Rheumatoid Arthritis Therapeutics Market Size Report

Rheumatoid Arthritis Therapeutics Market Size Analysis Report By Molecule Type (Biopharmaceuticals (Biologics, Biosimilars), Pharmaceuticals), By Sales Channel (Prescription, OTC), And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-313-3
  • Number of Pages: 85
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2014 - 2025)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α antagonists
        • T-cell inhibitors
        • CD20 antigen
        • JAK inhibitors
        • anti-IL6 biologics
      • Biosimilars
        • CD20 antigen
        • TNF-α antagonists
  • Rheumatoid Arthritis Therapeutics Sales channel Outlook (Revenue, USD Million, 2014 - 2025)
    • Prescription
    • Over-the-Counter (OTC)
  • Rheumatoid Arthritis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • North America Rheumatoid Arthritis Therapeutics Market, By Molecule type
        • Pharmaceuticals
          • NSAIDs
          • Analgesics
          • DMARDs
          • Glucocorticoids
        • Biopharmaceuticals
          • Biologics
            • TNF-α antagonists
            • T-cell inhibitors
            • CD20 antigen
            • JAK inhibitors
            • anti-IL6 biologics
          • Biosimilars
            • CD20 antigen
            • TNF-α antagonists
      • North America Rheumatoid Arthritis Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • The U.S.
        • U.S. Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • U.S. Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Canada
        • Canada Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • Canada Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Europe
      • Europe Rheumatoid Arthritis Therapeutics Market, By Molecule type
        • Pharmaceuticals
          • NSAIDs
          • Analgesics
          • DMARDs
          • Glucocorticoids
        • Biopharmaceuticals
          • Biologics
            • TNF-α antagonists
            • T-cell inhibitors
            • CD20 antigen
            • JAK inhibitors
            • anti-IL6 biologics
          • Biosimilars
            • CD20 antigen
            • TNF-α antagonists
      • Europe Rheumatoid Arthritis Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • The U.K.
        • U.K. Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • U.K. Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Germany
        • Germany Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • Germany Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Asia Pacific
      • Asia Pacific Rheumatoid Arthritis Therapeutics Market, By Molecule type
        • Pharmaceuticals
          • NSAIDs
          • Analgesics
          • DMARDs
          • Glucocorticoids
        • Biopharmaceuticals
          • Biologics
            • TNF-α antagonists
            • T-cell inhibitors
            • CD20 antigen
            • JAK inhibitors
            • anti-IL6 biologics
          • Biosimilars
            • CD20 antigen
            • TNF-α antagonists
      • Asia Pacific Rheumatoid Arthritis Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • China
        • China Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • China Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Japan
        • Japan Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • Japan Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • Latin America
      • Latin America Rheumatoid Arthritis Therapeutics Market, By Molecule type
        • Pharmaceuticals
          • NSAIDs
          • Analgesics
          • DMARDs
          • Glucocorticoids
        • Biopharmaceuticals
          • Biologics
            • TNF-α antagonists
            • T-cell inhibitors
            • CD20 antigen
            • JAK inhibitors
            • anti-IL6 biologics
          • Biosimilars
            • CD20 antigen
            • TNF-α antagonists
      • Latin America Rheumatoid Arthritis Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • Brazil
        • Brazil Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • Brazil Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
      • Mexico
        • Mexico Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • Mexico Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)
    • MEA
      • MEA Rheumatoid Arthritis Therapeutics Market, By Molecule type
        • Pharmaceuticals
          • NSAIDs
          • Analgesics
          • DMARDs
          • Glucocorticoids
        • Biopharmaceuticals
          • Biologics
            • TNF-α antagonists
            • T-cell inhibitors
            • CD20 antigen
            • JAK inhibitors
            • anti-IL6 biologics
          • Biosimilars
            • CD20 antigen
            • TNF-α antagonists
      • MEA Rheumatoid Arthritis Therapeutics Market, By Sales channel
        • Prescription
        • Over-the-Counter (OTC)
      • South Africa
        • South Africa Rheumatoid Arthritis Therapeutics Market, By Molecule type
          • Pharmaceuticals
            • NSAIDs
            • Analgesics
            • DMARDs
            • Glucocorticoids
          • Biopharmaceuticals
            • Biologics
              • TNF-α antagonists
              • T-cell inhibitors
              • CD20 antigen
              • JAK inhibitors
              • anti-IL6 biologics
            • Biosimilars
              • CD20 antigen
              • TNF-α antagonists
        • South Africa Rheumatoid Arthritis Therapeutics Market, By Sales channel
          • Prescription
          • Over-the-Counter (OTC)

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.